ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GSTC Globestar Therapeutics Corporation (PK)

0.0011
0.00 (0.00%)
Feb 21 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0.00
Bid Price 0.0001
Ask Price 0.08
News -
Day High

Low
0.00065

52 Week Range

High
0.011

Day Low
Company Name Stock Ticker Symbol Market Type
Globestar Therapeutics Corporation (PK) GSTC OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.0011 06:00:33
Open Price Low Price High Price Close Price Prev Close
0.0011
Trades Volume Avg Volume 52 Week Range
0 0.00 - 0.00065 - 0.011
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.0011 USD

Globestar Therapeutics Corporation (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 959.50k 872.27M 446.54M - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Globestar Therapeutics (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No GSTC Message Board. Create One! See More Posts on GSTC Message Board See More Message Board Posts

Historical GSTC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.001050.00120.00090.00115126,994,0420.000054.76%
1 Month0.00090.00150.000650.001079428,836,4820.000222.22%
3 Months0.001560.00170.000650.001106515,124,042-0.00046-29.49%
6 Months0.00270.00430.000650.00137359,591,481-0.0016-59.26%
1 Year0.00860.0110.000650.00232136,247,040-0.0075-87.21%
3 Years0.0730.0730.000650.00724494,856,926-0.0719-98.49%
5 Years0.0730.0730.000650.00724494,856,926-0.0719-98.49%

Globestar Therapeutics (PK) Description

GlobeStar Therapeutics Corporation ("GlobeStar"), headquartered in Richland, Washington, was incorporated in 2016 and owns breakthrough addition of treatment for Multiple Sclerosis and other neurodegenerative diseases as well other pharmaceuticals and nutraceutical. GlobeStar is a clinical stage pharmaceutical company testing a worldwide patented formulation of 3 drugs previously approved by the FDA. Pre-clinical trials in Italy showed the drug combination was effective in the reduction of MS co-morbidities. GlobeStar is initiating discussions with the FDA on clinical trial design in the U.S. in preparation for FDA submission and approval.

Your Recent History

Delayed Upgrade Clock